Author:
Preethy H Agnes,Rajendran Kayalvizhi,Sukumar Anitha Josephine,Krishnan Uma Maheswari
Reference332 articles.
1. Identification of BACE2 as an avid ß-amyloid-degrading protease;Abdul-Hay;Mol. Neurodegener.,2012
2. The influence of baseline Alzheimer's disease severity on cognitive decline and CSF biomarkers in the NILVAD trial;Abdullah;Front. Neurol.,2020
3. In silico molecular docking approach against enzymes causing Alzheimer's disease using borassus flabellifer linn;Abraham;Appl. Biochem. Biotechnol.,2022
4. Tramiprosate in mild-to-moderate Alzheimer's disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study);Aisen;Arch. Med. Sci.,2011
5. Natural product inhibitors as potential drug candidates against Alzheimer's disease: structural-based drug design, molecular docking, molecular dynamic simulation experiments, and ADMET predictions;Ajala;J. Indian Chem. Soc.,2023